NuCana logo

NuCana

NCNA | NASDAQ
Chart Builder DCF Calculator
$0.86
-$0.07 (-7.79%)
At close: Nov 16, 2026, 4:00 PM ET
$0.87
+$0.01 (+1.16%)
After-hours: Nov 16, 2026, 7:30 PM ET
-7.79%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #960/1021 (Top 94%)

Key Statistics

Market Data

Market Cap $5.24M
1D Range
0.86 0.94
52W Range
0.86 4.43

Valuation (TTM)

PE -0.20
PB 0.20
EV/EBITDA 1.11

Valuation (NTM)

Forward PE N/A
Forward PEG -0.75
Price Target $0.00
Loading financial charts...

Profile

NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platfo...

Sector Healthcare
Industry Biotechnology
Employees 11
IPO Date Sep 28, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.